NewsRoom Articles - Page 61 of 214

WednesdaySep 20, 2023 9:00 am

Generic Drug Manufacturer SOHM, Inc. (SHMN) Building Regenerative Medicine Platform with LOI for Gene Editing Technology

U.S.-based generic drug developer SOHM is working to build its product pipeline through registration for distribution in several states and the planned establishment of its own product manufacturing plant in Southern California SOHM is also focused on developing a regenerative medicine portfolio, having issued an LOI recently in its bid to acquire the gene editing technology ABBIE from CGA Intellectual Holdings Inc. ABBIE is a synthetic enzyme technology that includes a DNA binding solution and a DNA integration solution for introducing a functionally edited genome into an “enhanced” cell that could then be introduced into a patient’s body to repair…

TuesdaySep 19, 2023 1:48 pm

Study Shows Climate Change Impacts Infectious Disease Risks

European researchers have published a study associating climate change with the prevalence of infectious disease transmission. The continent-wide study analyzed the prevalence of viruses, bacteria and protozoans that have the potential to infect humans, domestic animals and bats in various climates. The researchers found that rainfall and temperature could affect the prevalence of several potentially pathogenic microorganisms. They investigated more than 75 microbes from an estimated 40 bat and 400 bird species across the European continent and compared their prevalence to different climatic conditions. Increased temperatures and extreme weather events often come to mind when most people think about the…

MondaySep 18, 2023 11:48 am

UI Research Suggests Immune System Can Be Trained to Combat Solid Tumors

New research from the University of Illinois suggests that scientists can leverage the immune system to combat more types of cancer than previous research indicated. A recent study analyzing the effectiveness of treatments that use chimeric antigen receptor T cells to fight cancer cells found that cancer therapies that involve modifying CAR-T cells to improve their anticancer capabilities may also be effective at fighting solid tumors. Past research and plenty of real-world evidence have consistently shown that cancers without solid tumors such as lymphoma and leukemia can be treated through immunotherapies. However, this treatment exhibited barely any effectiveness against cancers…

FridaySep 15, 2023 2:20 pm

Five Considerations When Taking eCommerce Brands Global

For any new company looking to succeed in this age of virtual trade, finding ways to stand out from the rest of the pack will be integral to building a successful brand, especially on the global stage. Adapting your branding to unique audiences should be your first consideration when launching products in foreign markets. This may include researching local cultures and understanding the language and any symbolism locals may place with certain names, packaging or colors. American beauty product and skincare company Estée Lauder learned this lesson when it launched a project in Germany without realizing that the product’s name…

ThursdaySep 14, 2023 9:45 am

Longeveron Inc. (NASDAQ: LGVN) to Discuss Its Cellular Therapy Programs, Clinical Trial Progress at the 25th Annual H.C. Wainwright Global Investment Conference

Longeveron management will present at the 25th Annual H.C. Wainwright Global Investment Conference scheduled for September 11-13, 2023, in New York Wa’el Hashad, the company’s CEO, will discuss Longeveron’s cellular therapy programs in a pre-recorded presentation. Both he and Lisa Locklear, EVP & Chief Financial Officer, will be at the conference to discuss the company’s investment strategies and clinical trial progress The company aims to create awareness among scientists and investors of its clinical trial progress, positive clinical results, and cellular therapy programs Longeveron is evaluating its lead investigational product candidate, a cellular product named Lomecel-B(TM), in ongoing clinical trials…

ThursdaySep 14, 2023 9:00 am

Leadership Changes At SOHM, Inc. (SHMN) to Strengthen Growth Strategies for Generic Drug Market and Gene Editing Platform Development

U.S.-based generic drug developer SOHM recently announced the addition of two leading officers — Dr. David Aguilar (Ph.D) as Chief Operating Officer and Dr. Krishna Bhat (MD, Ph.D, FACC) as Chief Medical Advisor The new officers are expected to help direct SOHM’s global growth strategy as the company continues to develop and diversify its product offerings, which include a variety of mediums for administering antibiotics, analgesics, anti-inflammatory and anti-cold therapies, as well as vitamins SOHM also recently announced an LOI to acquire a stem cell disruptive technology and related patents, which include the potential for someday treating damaged hearts via…

ThursdaySep 14, 2023 9:00 am

Microdevices to Enable Simultaneous Multiple Studies on Potential Brain Cancer Treatments

Brigham and Women’s Hospital scientists have developed a microdevice to help researchers test the effectiveness of glioma treatments. Gliomas are a type of brain tumor that arise from glial cells in the spinal cord and brain before infiltrating surrounding brain cells. Because the proximity of gliomas to healthy brain cells makes them hard to remove via surgery, glioma treatment often involves removing as much of the tumor via surgery before using chemotherapy or radiation therapy to kill off as many of the remaining cancer cells as possible. Furthermore, researchers find it extremely difficult to test the effects of different drug…

WednesdaySep 13, 2023 1:01 pm

Why Food Allergy Prevalence Is Growing

The director of population health research at the Northwest University’s Center for Food Allergy and Asthma Research suggests that increasing food allergy rates in the developed world may be partly due to advancements in medicine and certain parental habits. By the 1980s, Northwest University Professor Christopher Warren says, the United States had mostly eliminated tapeworms and hookworms. Without any actual threats to deal with, our immune systems downgraded their attention to relatively harmless allergens such as birch pollen and walnuts. Anecdotal results from some researchers who injected themselves with hookworms found that introducing the parasite into their systems somewhat distracted…

WednesdaySep 13, 2023 10:30 am

PaxMedica Inc. (NASDAQ: PXMD) Is ‘One to Watch’

PaxMedica recently announced positive top line results from its PAX-101 Phase 3 African Sleeping Sickness Study, paving the way for an expected New Drug Application filing in 2024 The company granted exclusive pharmacy distribution for PAX-101 to Vox Nova LLC, the first purpose-built limited distribution specialty pharmacy benefit manager for people with ASD PaxMedica submitted PAX-101 Clinical Trial Request to the South African Health Products Regulatory Authority, requesting approval for a double-blind, placebo-controlled study in ASD The company entered a Research Collaboration Agreement with PoloMar Health and The BRAIN Foundation for a Phase II proof-of-concept trial in ASD PaxMedica (NASDAQ:…

TuesdaySep 12, 2023 10:20 am

Stack Foundation Gives UC San Diego $5M Gift to Advance Gene Therapy

The Stack Foundation has gifted $5 million to the University of California San Diego (UC San Diego) to facilitate gene therapy research for the development of new treatments for genetic disorders in adults and children. UC San Diego said in a recent statement it would launch a Gene Therapy Initiative to meet the need for safer and more effective therapies. Genetic diseases affect fewer than 200,000 people in the United States and can be incredibly hard to treat, especially in the case of rare genetic disorders that have fewer patients to study for the development of effective therapies. Thanks to…